<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Nadolol.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:05 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="filelist-352.xml.html" tppabs="http://www.vietstarse.com/duocthu/Documents/Nadolol_files/filelist.xml">
<link rel=Edit-Time-Data href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Nadolol_files/editdata.mso  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Nadolol_files/editdata.mso'" tppabs="http://www.vietstarse.com/duocthu/Documents/Nadolol_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>NADOLOL</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VS35</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>9</o:TotalTime>
  <o:Created>2006-08-08T14:08:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:27:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>1610</o:Words>
  <o:Characters>9179</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>76</o:Lines>
  <o:Paragraphs>21</o:Paragraphs>
  <o:CharactersWithSpaces>10768</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	page-break-before:always;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:12.0pt;
	font-family:Tahoma;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:467.8pt 722.95pt;
	margin:56.7pt 36.75pt 56.7pt 28.35pt;
	mso-header-margin:28.35pt;
	mso-footer-margin:42.55pt;
	mso-page-numbers:85;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
@page Section2
	{size:467.8pt 722.95pt;
	margin:56.7pt 28.35pt 56.7pt 28.35pt;
	mso-header-margin:28.35pt;
	mso-footer-margin:42.55pt;
	mso-page-numbers:1;
	mso-paper-source:0;}
div.Section2
	{page:Section2;}
@page Section3
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section3
	{page:Section3;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>NADOLOL<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tên chung qu&#7889;c t&#7871;:</span></b><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'> Nadolol.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Mã ATC: </span></b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>C07A
A12.<b><o:p></o:p></b></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lo&#7841;i
thu&#7889;c: </span></b><span style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana'>Thu&#7889;c ch&#7865;n beta - adrenergic không ch&#7885;n
l&#7885;c.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng
thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Viên nén
u&#7889;ng: 20 mg; 40 mg; 80 mg; 120 mg; <br>
160 mg.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
lý và c&#417; ch&#7871; tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nadolol
là thu&#7889;c ch&#7865;n beta - adrenergic không ch&#7885;n l&#7885;c, tác d&#7909;ng
kéo dài, có ái l&#7921;c v&#7899;i th&#7909; th&#7875; beta - 1 và beta - 2
ngang nhau. Thu&#7889;c không có ho&#7841;t tính &#7893;n &#273;&#7883;nh màng
và ho&#7841;t tính gi&#7889;ng th&#7847;n kinh giao c&#7843;m n&#7897;i t&#7841;i;
thu&#7889;c phong b&#7871; c&#7841;nh tranh &#273;áp &#7913;ng v&#7899;i kích
thích beta - 1 và beta - 2. Các thu&#7889;c &#273;&#7889;i kháng beta, trong
&#273;ó có nadolol, &#273;&#432;&#7907;c quan tâm nhi&#7873;u &#7903; lâm sàng
vì hi&#7879;u qu&#7843; trong &#273;i&#7873;u tr&#7883; t&#259;ng huy&#7871;t
áp, b&#7879;nh thi&#7871;u máu c&#7909;c b&#7897; c&#417; tim và m&#7897;t s&#7889;
th&#7875; lo&#7841;n nh&#7883;p. Các tác d&#7909;ng &#273;i&#7873;u tr&#7883;
ch&#7911; y&#7871;u là trên h&#7879; tim m&#7841;ch. Thu&#7889;c làm ch&#7853;m
t&#7847;n s&#7889; tim và gi&#7843;m s&#7913;c co c&#417; tim. Khi h&#7879; th&#7847;n
kinh giao c&#7843;m &#273;&#432;&#7907;c ho&#7841;t hóa, nh&#432; trong khi luy&#7879;n
t&#7853;p ho&#7863;c stress, các thu&#7889;c &#273;&#7889;i kháng beta -
adrenergic gi&#7843;m b&#7899;t t&#259;ng t&#7847;n s&#7889; tim &#273;áng có,
do &#273;ó ng&#432;&#7901;i b&#7879;nh &#273;au th&#7855;t ng&#7921;c th&#432;&#7901;ng
ch&#7883;u &#273;&#7921;ng g&#7855;ng s&#7913;c t&#7889;t h&#417;n. Dùng thu&#7889;c
th&#7901;i gian ng&#7855;n làm gi&#7843;m hi&#7879;u su&#7845;t tim; s&#7913;c
kháng ngo&#7841;i biên t&#259;ng do ch&#7865;n th&#7909; th&#7875; beta - 2 &#7903;
m&#7841;ch và ph&#7843;n x&#7841; bù giao c&#7843;m gây ho&#7841;t hóa th&#7909;
th&#7875; alpha adrenergic &#7903; m&#7841;ch. Tuy v&#7853;y, khi s&#7917; d&#7909;ng
th&#7901;i gian dài, s&#7913;c kháng ngo&#7841;i biên toàn ph&#7847;n tr&#7903;
l&#7841;i tr&#7883; s&#7889; ban &#273;&#7847;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
ch&#7865;n beta làm gi&#7843;m huy&#7871;t áp &#7903; ng&#432;&#7901;i
t&#259;ng huy&#7871;t áp; ng&#259;n ch&#7863;n gi&#7843;i phóng renin t&#7915;
b&#7897; ph&#7853;n c&#7853;n c&#7847;u th&#7853;n. Dùng dài ngày thu&#7889;c
này cho ng&#432;&#7901;i t&#259;ng huy&#7871;t áp cu&#7889;i cùng d&#7851;n
&#273;&#7871;n gi&#7843;m s&#7913;c kháng m&#7841;ch máu ngo&#7841;i biên. S&#7913;c
kháng m&#7841;ch ngo&#7841;i biên này gi&#7843;m ch&#7853;m, m&#7863;c d&#7847;u
hi&#7879;u su&#7845;t tim gi&#7843;m kéo dài, có th&#7875; gi&#7843;i thích cho
ph&#7847;n l&#7899;n tác d&#7909;ng ch&#7889;ng t&#259;ng huy&#7871;t áp c&#7911;a
thu&#7889;c. Nadolol có hi&#7879;u qu&#7843; nh&#432; propranolol trên ng&#432;&#7901;i
t&#259;ng huy&#7871;t áp và ng&#432;&#7901;i &#273;au th&#7855;t ng&#7921;c.
Nadolol có th&#7875; làm gi&#7843;m t&#7847;n s&#7889; c&#417;n &#273;au th&#7855;t
ng&#7921;c &#7903; ng&#432;&#7901;i có c&#417;n th&#432;&#7901;ng xuyên. Nh&#7919;ng
thu&#7889;c &#273;&#7889;i kháng beta - adrenergic không ch&#7885;n l&#7885;c
ch&#7865;n các th&#7909; th&#7875; beta - 2 &#7903; c&#417; tr&#417;n ph&#7871;
qu&#7843;n, nên gây nguy c&#417; c&#417;n hen c&#7845;p tính &#7903; ng&#432;&#7901;i
có b&#7879;nh hen ho&#7863;c b&#7879;nh ph&#7893;i t&#7855;c ngh&#7869;n m&#7841;n
tính. S&#7921; phong b&#7871; này có th&#7875; d&#7851;n &#273;&#7871;n co th&#7855;t
ph&#7871; qu&#7843;n &#273;e d&#7885;a tính m&#7841;ng. &#7902; ng&#432;&#7901;i
b&#7879;nh &#273;i&#7873;u tr&#7883; b&#7857;ng thu&#7889;c ch&#7865;n beta,
adrenalin không có tác d&#7909;ng khi b&#7883; ph&#7843;n &#7913;ng ph&#7843;n
v&#7879; mà ph&#7843;i dùng salbutamol.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nhi&#7873;u
thu&#7889;c &#273;&#7889;i kháng beta, trong có nadolol, có hi&#7879;u qu&#7843;
d&#7921; phòng ch&#7913;ng &#273;au n&#7917;a &#273;&#7847;u. Tác d&#7909;ng ch&#7889;ng
ch&#7913;ng &#273;au n&#7917;a &#273;&#7847;u không t&#432;&#417;ng quan v&#7899;i
hi&#7879;u l&#7921;c &#7903; th&#7909; th&#7875; beta, vì không ph&#7843;i t&#7845;t
c&#7843; thu&#7889;c &#273;&#7889;i kháng th&#7909; th&#7875; beta &#273;&#7873;u
có tác d&#7909;ng ch&#7889;ng ch&#7913;ng &#273;au n&#7917;a &#273;&#7847;u. Kh&#7843;
n&#259;ng c&#7911;a m&#7897;t s&#7889; thu&#7889;c &#273;&#7889;i kháng beta
&#273;i&#7873;u hoà h&#7879; serotoninergic có th&#7875; góp ph&#7847;n vào hi&#7879;u
qu&#7843; ch&#7889;ng ch&#7913;ng &#273;au n&#7917;a &#273;&#7847;u. <o:p></o:p></span></p>

<h2 align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
font-weight:normal'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c<o:p></o:p></span></i></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nadolol
d&#7877; tan trong n&#432;&#7899;c và &#273;&#432;&#7907;c h&#7845;p thu không
hoàn toàn qua ru&#7897;t; kh&#7843; d&#7909;ng sinh h&#7885;c kho&#7843;ng 35%.
Nadolol ít hoà tan trong lipid nên có n&#7891;ng &#273;&#7897; th&#7845;p trong
não. Nadolol không chuy&#7875;n hóa nhi&#7873;u, nên th&#7843;i tr&#7915; nhi&#7873;u
trong n&#432;&#7899;c ti&#7875;u d&#432;&#7899;i d&#7841;ng không bi&#7871;n
&#273;&#7893;i. Th&#7843;i tr&#7915; trong n&#432;&#7899;c ti&#7875;u: 73 ± 4%.
N&#7917;a &#273;&#7901;i trong huy&#7871;t t&#432;&#417;ng: 16 ± 2 gi&#7901;;
do &#273;ó, th&#432;&#7901;ng dùng thu&#7889;c ngày m&#7897;t l&#7847;n. Liên k&#7871;t
protein huy&#7871;t t&#432;&#417;ng: 20 ± 4%. Ð&#7897; thanh th&#7843;i: 2,9 ±
0,6 ml/kg cho 1 phút. Th&#7875; tích phân b&#7889;: 1,9 ± 0,2 lít/kg.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
&#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ði&#7873;u
tr&#7883; t&#259;ng huy&#7871;t áp, dùng m&#7897;t mình ho&#7863;c ph&#7889;i h&#7907;p
v&#7899;i nh&#7919;ng lo&#7841;i thu&#7889;c ch&#7889;ng t&#259;ng huy&#7871;t
áp khác.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ði&#7873;u
tr&#7883; d&#7921; phòng dài h&#7841;n ch&#7913;ng &#273;au th&#7855;t ng&#7921;c
m&#7841;n tính &#7893;n &#273;&#7883;nh.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dùng
&#273;&#7875; gi&#7843;m t&#7847;n s&#7889; th&#7845;t trong nh&#7883;p xoang
nhanh, rung nh&#297;, cu&#7891;ng nh&#297;, nhanh k&#7883;ch phát trên th&#7845;t
và c&#7843; ngo&#7841;i tâm thu th&#7845;t ho&#7863;c nh&#297;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7921;
phòng ch&#7913;ng &#273;au n&#7917;a &#273;&#7847;u.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>S&#7889;c
do tim, nh&#7883;p tim ch&#7853;m ho&#7863;c bl&#7889;c tim, quá m&#7851;n v&#7899;i
m&#7885;i thành ph&#7847;n c&#7911;a thu&#7889;c, hen ph&#7871; qu&#7843;n, co
th&#7855;t ph&#7871; qu&#7843;n. Nhi&#7877;m toan chuy&#7875;n hóa.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tuy 1
vài thu&#7889;c ch&#7865;n beta &#273;&#432;&#7907;c dùng nh&#432; 1 ph&#7847;n
trong &#273;i&#7873;u tr&#7883; suy tim, nh&#432;ng thông th&#432;&#7901;ng thu&#7889;c
ch&#7865;n beta không nên cho trong suy tim tr&#7915; khi &#273;ã &#273;&#432;&#7907;c
ki&#7875;m soát và ngay khi &#273;ó v&#7851;n c&#7847;n ph&#7843;i th&#7853;n
tr&#7885;ng, nên dành cho th&#7847;y thu&#7889;c chuyên khoa tim m&#7841;ch.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Vi&#7879;c
ng&#7915;ng &#273;&#7897;t ng&#7897;t li&#7879;u pháp dùng thu&#7889;c ch&#7865;n
beta &#7903; ng&#432;&#7901;i có &#273;au th&#7855;t ng&#7921;c và/ho&#7863;c b&#7879;nh
&#273;&#7897;ng m&#7841;ch vành có th&#7875; làm b&#7879;nh n&#7863;ng thêm. Do
&#273;ó, ph&#7843;i báo tr&#432;&#7899;c cho ng&#432;&#7901;i b&#7879;nh dùng
nadolol là không &#273;&#432;&#7907;c dùng gián &#273;o&#7841;n ho&#7863;c ng&#7915;ng
dùng thu&#7889;c mà ch&#432;a h&#7887;i ý ki&#7871;n bác s&#7929;. Ph&#7843;i
gi&#7843;m li&#7873;u d&#7847;n d&#7847;n trong th&#7901;i gian kho&#7843;ng 1
- 2 tu&#7847;n và theo dõi c&#7849;n th&#7853;n ng&#432;&#7901;i b&#7879;nh
tr&#432;&#7899;c khi ng&#7915;ng thu&#7889;c. Không dùng nadolol cho ng&#432;&#7901;i
có co th&#7855;t ph&#7871; qu&#7843;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ph&#7843;i
theo dõi ch&#7863;t ch&#7869; ng&#432;&#7901;i b&#7879;nh có ho&#7863;c nghi ng&#7901;
có nhi&#7877;m &#273;&#7897;c giáp vì vi&#7879;c ng&#7915;ng &#273;&#7897;t ng&#7897;t
thu&#7889;c ch&#7865;n - beta có th&#7875; thúc &#273;&#7849;y c&#417;n c&#432;&#7901;ng
giáp c&#7845;p. &#7902; ng&#432;&#7901;i &#273;&#432;&#7907;c &#273;&#7841;i ph&#7851;u
thu&#7853;t có gây mê, n&#7871;u có th&#7875;, ng&#7915;ng dùng nadolol
tr&#432;&#7899;c khi ph&#7851;u thu&#7853;t. Gi&#7843;m huy&#7871;t áp n&#7863;ng
và khó ph&#7909;c h&#7891;i ho&#7863;c khó duy trì nh&#7883;p &#273;&#7853;p c&#7911;a
tim &#273;ã x&#7843;y ra trong khi ph&#7851;u thu&#7853;t &#7903; ng&#432;&#7901;i
&#273;ang dùng thu&#7889;c ch&#7865;n beta. N&#7871;u ti&#7871;p t&#7909;c dùng
nadolol trong khi ph&#7851;u thu&#7853;t, ph&#7843;i báo cho bác s&#297; gây mê
bi&#7871;t là ng&#432;&#7901;i b&#7879;nh &#273;ang dùng thu&#7889;c này. &#7902;
ng&#432;&#7901;i có suy th&#7853;n ho&#7863;c suy gan, ph&#7843;i s&#7917; d&#7909;ng
th&#7853;n tr&#7885;ng nadolol; có th&#7875; c&#7847;n ph&#7843;i gi&#7843;m li&#7873;u
trong suy th&#7853;n. Ng&#432;&#7901;i b&#7883; u t&#7871; bào &#432;a crom
không &#273;&#432;&#7907;c dùng thu&#7889;c ch&#7865;n beta n&#7871;u không
dùng li&#7879;u pháp ch&#7865;n alpha adrenergic &#273;&#7891;ng th&#7901;i.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tránh
dùng nadolol trong th&#7901;i k&#7923; mang thai, &#273;&#7863;c bi&#7879;t
trong 3 tháng cu&#7889;i, và ch&#7881; dùng khi nh&#7919;ng l&#7907;i ích có th&#7875;
thu &#273;&#432;&#7907;c tr&#7897;i h&#417;n nguy c&#417; có th&#7875; x&#7843;y
ra v&#7899;i thai. N&#7871;u ng&#432;&#7901;i m&#7865; dùng nadolol khi mang thai
thì tr&#7867; s&#417; sinh s&#7869; có bi&#7875;u hi&#7879;n nh&#7883;p tim ch&#7853;m,
h&#7841; &#273;&#432;&#7901;ng máu và nh&#7919;ng tri&#7879;u ch&#7913;ng k&#7871;t
h&#7907;p.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nadolol
&#273;&#432;&#7907;c phân b&#7889; trong s&#7919;a m&#7865;. Vì có th&#7875; có
tác d&#7909;ng không mong mu&#7889;n &#7903; tr&#7867; nh&#7887; bú s&#7919;a m&#7865;,
nên c&#7847;n ph&#7843;i cân nh&#7855;c xem nên ng&#7915;ng cho bú hay ng&#7915;ng
dùng thu&#7889;c, có l&#432;u ý &#273;&#7871;n t&#7847;m quan tr&#7885;ng c&#7911;a
thu&#7889;c v&#7899;i ng&#432;&#7901;i m&#7865;.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;text-indent:
.4in;line-height:150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ph&#7847;n
l&#7899;n ADR c&#7911;a nadolol &#273;&#7873;u nh&#7865; và nh&#7845;t th&#7901;i,
và th&#432;&#7901;ng g&#7863;p khi b&#7855;t &#273;&#7847;u &#273;i&#7873;u tr&#7883;
nhi&#7873;u h&#417;n trong khi &#273;i&#7873;u tr&#7883; kéo dài. ADR nghiêm tr&#7885;ng
th&#432;&#7901;ng g&#7863;p nh&#7845;t có liên quan v&#7899;i ho&#7841;t tính
ch&#7865;n beta. ADR nghiêm tr&#7885;ng x&#7843;y ra do ng&#432;&#7901;i &#7889;m
n&#7863;ng không ch&#7883;u &#273;&#7921;ng &#273;&#432;&#7907;c s&#7921; gi&#7843;m
kích thích beta - adrenergic bình th&#432;&#7901;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;text-indent:.4in;
line-height:150%'><i><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></i></p>

<p class=MsoBodyText2 align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:150%'><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>Tim m&#7841;ch: Nh&#7883;p tim ch&#7853;m,
thi&#7875;u n&#259;ng m&#7841;ch ngo&#7841;i biên, suy tim, h&#7841; huy&#7871;t
áp t&#432; th&#7871;, bl&#7889;c d&#7851;n truy&#7873;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7847;n
kinh trung &#432;&#417;ng: Chóng m&#7863;t, m&#7879;t m&#7887;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ít g&#7863;p,
1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7847;n
kinh trung &#432;&#417;ng: D&#7883; c&#7843;m, bu&#7891;n ng&#7911;, khó ch&#7883;u,
thay &#273;&#7893;i hành vi, nh&#7913;c &#273;&#7847;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tim m&#7841;ch:
Phù.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tiêu
hóa: Bu&#7891;n nôn, &#7881;a ch&#7843;y, b&#7909;ng khó ch&#7883;u, táo bón,
nôn, khó tiêu, chán &#259;n, ch&#432;&#7899;ng b&#7909;ng, &#273;&#7847;y
h&#417;i, mi&#7879;ng khô.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Hô h&#7845;p:
Co th&#7855;t ph&#7871; qu&#7843;n, ho, ng&#7841;t m&#361;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Da: Ban,
ng&#7913;a, da khô, r&#7909;ng tóc có h&#7891;i ph&#7909;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>M&#7855;t:
M&#7855;t khô, nhìn m&#7901;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7897;i
ti&#7871;t và chuy&#7875;n hóa: Gi&#7843;m kh&#7843; n&#259;ng sinh d&#7909;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Sinh d&#7909;c
- ti&#7871;t ni&#7879;u: Li&#7879;t d&#432;&#417;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7847;n
kinh - c&#417; và x&#432;&#417;ng: Y&#7871;u &#7899;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Huy&#7871;t
h&#7885;c: Gi&#7843;m ti&#7875;u c&#7847;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Khác:
Chân tay l&#7841;nh, ù tai, ra m&#7891; hôi.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng
d&#7851;n cách x&#7917; trí ADR<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Có th&#7875;
&#273;i&#7873;u tr&#7883; nh&#7883;p tim ch&#7853;m nghiêm tr&#7885;ng b&#7857;ng
tiêm b&#7855;p th&#7883;t ho&#7863;c t&#297;nh m&#7841;ch atropin sulfat. N&#7871;u
hi&#7879;u qu&#7843; ch&#432;a &#273;&#7847;y &#273;&#7911; v&#7899;i atropin,
tiêm t&#297;nh m&#7841;ch isoproterenol, nh&#432;ng ph&#7843;i th&#7853;n tr&#7885;ng.
&#7902; ng&#432;&#7901;i b&#7879;nh dùng nadolol, c&#7847;n &#273;i&#7873;u tr&#7883;
m&#7897;t cách thích h&#7907;p (ví d&#7909;, v&#7899;i m&#7897;t glycosid tr&#7907;
tim và/ho&#7863;c thu&#7889;c l&#7907;i ti&#7875;u) khi có d&#7845;u hi&#7879;u
ho&#7863;c tri&#7879;u ch&#7913;ng &#273;&#7847;u tiên v&#7873; suy tim s&#7855;p
x&#7843;y ra, và theo dõi c&#7849;n th&#7853;n ng&#432;&#7901;i b&#7879;nh; n&#7871;u
suy tim ti&#7871;p t&#7909;c, ph&#7843;i ng&#7915;ng nadolol d&#7847;n d&#7847;n
n&#7871;u có th&#7875;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7871;u
&#273;au th&#7855;t ng&#7921;c t&#259;ng lên ho&#7863;c phát tri&#7875;n thi&#7875;u
n&#259;ng &#273;&#7897;ng m&#7841;ch vành c&#7845;p tính sau khi ng&#7915;ng
&#273;i&#7873;u tr&#7883; b&#7857;ng nadolol, ph&#7843;i nhanh chóng &#273;i&#7873;u
tr&#7883; l&#7841;i b&#7857;ng nadolol, ít nh&#7845;t là t&#7841;m th&#7901;i,
và th&#7921;c hi&#7879;n bi&#7879;n pháp thích h&#7907;p &#273;&#7875; &#273;i&#7873;u
tr&#7883; &#273;au th&#7855;t ng&#7921;c không &#7893;n &#273;&#7883;nh. Có th&#7875;
&#273;i&#7873;u tr&#7883; ADR c&#7911;a nadolol trong khi ph&#7851;u thu&#7853;t,
b&#7857;ng tiêm t&#297;nh m&#7841;ch thu&#7889;c ch&#7911; v&#7853;n beta (ví d&#7909;,
isoproterenol, dopamin, ho&#7863;c dobutamin).<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
l&#432;&#7907;ng và cách dùng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Cách
dùng</span></i><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>: Nadolol u&#7889;ng ngày m&#7897;t l&#7847;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
l&#432;&#7907;ng:</span></i><span style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana'> Không có m&#7889;i liên quan &#7893;n &#273;&#7883;nh
gi&#7919;a li&#7873;u l&#432;&#7907;ng nadolol và hi&#7879;u qu&#7843; &#273;i&#7873;u
tr&#7883; &#7903; các ng&#432;&#7901;i b&#7879;nh khác nhau, nên ph&#7843;i xác
&#273;&#7883;nh li&#7873;u tùy theo hi&#7879;u qu&#7843; trên t&#7915;ng cá
nhân.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ði&#7873;u
tr&#7883; t&#259;ng huy&#7871;t áp</span></i><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>: Li&#7873;u nadolol b&#7855;t
&#273;&#7847;u cho ng&#432;&#7901;i l&#7899;n là 20 - 40 mg m&#7895;i ngày,
dùng &#273;&#417;n &#273;&#7897;c ho&#7863;c k&#7871;t h&#7907;p v&#7899;i thu&#7889;c
l&#7907;i ti&#7875;u. T&#259;ng d&#7847;n li&#7873;u, m&#7895;i l&#7847;n
t&#259;ng 40 - 80 mg/ngày, &#7903; nh&#7919;ng kho&#7843;ng cách t&#7915; 2
&#273;&#7871;n 14 ngày, cho t&#7899;i khi &#273;&#7841;t &#273;&#432;&#7907;c
hi&#7879;u qu&#7843; t&#7889;i &#432;u trên huy&#7871;t áp. Li&#7873;u duy trì
th&#432;&#7901;ng dùng c&#7911;a nadolol là 40 ho&#7863;c 80 mg m&#7897;t ngày,
có th&#7875; c&#7847;n dùng nh&#7919;ng li&#7873;u t&#7899;i 240 mg ho&#7863;c
320 mg m&#7895;i ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ði&#7873;u
tr&#7883; &#273;au th&#7855;t ng&#7921;c:</span></i><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> Li&#7873;u nadolol b&#7855;t
&#273;&#7847;u cho ng&#432;&#7901;i l&#7899;n là 40 mg m&#7897;t ngày.
T&#259;ng d&#7847;n li&#7873;u, m&#7895;i l&#7847;n t&#259;ng 40 - 80 mg/ngày, &#7903;
nh&#7919;ng kho&#7843;ng cách t&#7915; 3 &#273;&#7871;n 7 ngày, cho t&#7899;i
khi &#273;&#7841;t &#273;&#432;&#7907;c s&#7921; ki&#7875;m soát t&#7889;i
&#432;u &#273;au th&#7855;t ng&#7921;c, ho&#7863;c có s&#7921; ch&#7853;m rõ r&#7879;t
nh&#7883;p tim. Li&#7873;u duy trì th&#432;&#7901;ng dùng là 40 ho&#7863;c 80
mg nadolol m&#7895;i ngày, nh&#432;ng có s&#7921; thay &#273;&#7893;i khá r&#7897;ng
v&#7873; nhu c&#7847;u c&#7911;a t&#7915;ng cá nhân, nên ph&#7843;i dò li&#7873;u
c&#7849;n th&#7853;n &#273;&#7875; &#273;&#7841;t k&#7871;t qu&#7843; t&#7889;i
&#432;u. Có th&#7875; c&#7847;n dùng li&#7873;u t&#7899;i 160 ho&#7863;c 240 mg
m&#7895;i ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Công d&#7909;ng
khác</span></i><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'> - Trong lo&#7841;n nh&#7883;p tim, li&#7873;u duy trì là
40 - 160 mg nadolol m&#7897;t ngày, u&#7889;ng m&#7897;t l&#7847;n ho&#7863;c
chia thành m&#7897;t s&#7889; l&#7847;n. Ð&#7875; d&#7921; phòng ch&#7913;ng
&#273;au n&#7917;a &#273;&#7847;u, li&#7873;u hàng ngày là 40 - 80 mg nadolol.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
l&#432;&#7907;ng trong suy th&#7853;n</span></i><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> U&#7889;ng li&#7873;u nadolol
th&#432;&#7901;ng dùng &#7903; nh&#7919;ng kho&#7843;ng cách sau &#273;ây, tùy
theo &#273;&#7897; thanh th&#7843;i creatinin:<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><!--[if gte vml 1]><o:wrapblock><v:shapetype
  id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
  path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
  <v:stroke joinstyle="miter"/>
  <v:formulas>
   <v:f eqn="if lineDrawn pixelLineWidth 0"/>
   <v:f eqn="sum @0 1 0"/>
   <v:f eqn="sum 0 0 @1"/>
   <v:f eqn="prod @2 1 2"/>
   <v:f eqn="prod @3 21600 pixelWidth"/>
   <v:f eqn="prod @3 21600 pixelHeight"/>
   <v:f eqn="sum @0 0 1"/>
   <v:f eqn="prod @6 1 2"/>
   <v:f eqn="prod @7 21600 pixelWidth"/>
   <v:f eqn="sum @8 21600 0"/>
   <v:f eqn="prod @7 21600 pixelHeight"/>
   <v:f eqn="sum @10 21600 0"/>
  </v:formulas>
  <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
  <o:lock v:ext="edit" aspectratio="t"/>
 </v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t75" style='position:absolute;
  margin-left:27pt;margin-top:0;width:411pt;height:78pt;z-index:1'>
  <v:imagedata src="Nadolol_files/image001.png" o:title=""/>
  <w:wrap type="topAndBottom"/>
 </v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=36 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=548 height=104 src="image003-7.gif" tppabs="http://www.vietstarse.com/duocthu/Documents/Nadolol_files/image003.gif" v:shapes="_x0000_s1026"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p></o:p></span></p>

</div>

<span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Tahoma;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'><br clear=all style='page-break-before:auto;mso-break-type:section-break'>
</span>

<div class=Section2></div>

<b><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Tahoma;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'><br clear=all style='page-break-before:always;mso-break-type:section-break'>
</span></b>

<div class=Section3>

<p class=MsoCaption align=left style='margin-top:0in;text-align:left;
text-indent:.4in;line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Mu&#7889;i
nhôm, barbiturat, mu&#7889;i calci, cholestyramin, colestipol, thu&#7889;c ch&#7889;ng
viêm không steroid, penicilin ho&#7863;c ampicilin, rifampicin, salicylat và
sulfinpyrazon làm gi&#7843;m tác d&#7909;ng c&#7911;a thu&#7889;c ch&#7865;n -
beta do gi&#7843;m sinh kh&#7843; d&#7909;ng và n&#7891;ng &#273;&#7897; thu&#7889;c
trong huy&#7871;t t&#432;&#417;ng. Thu&#7889;c ch&#7865;n beta làm gi&#7843;m
tác d&#7909;ng c&#7911;a sulfonylurea, và c&#7911;a thu&#7889;c ch&#7911; v&#7853;n
beta.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
ch&#7865;n calci (diltiazem, felodipin, nicardipin), thu&#7889;c tránh thai,
flecainid, thu&#7889;c &#7913;c ch&#7871; MAO, quinidin, ciprofloxacin làm
t&#259;ng tác d&#7909;ng/&#273;&#7897;c tính c&#7911;a thu&#7889;c ch&#7865;n -
beta. Thu&#7889;c ch&#7865;n - beta có th&#7875; làm t&#259;ng tác d&#7909;ng/&#273;&#7897;c
tính c&#7911;a flecainid, phenothiazin, paracetamol, clonidin (c&#417;n
t&#259;ng huy&#7871;t áp sau ho&#7863;c trong khi ng&#7915;ng m&#7897;t trong
hai thu&#7889;c), adrenalin (giai &#273;o&#7841;n t&#259;ng huy&#7871;t áp ban
&#273;&#7847;u kèm theo nh&#7883;p tim ch&#7853;m), nifedipin và verapamil,
lidocain, n&#7845;m c&#7921;a gà (thi&#7871;u máu c&#7909;c b&#7897; ngo&#7841;i
biên), prazosin (h&#7841; huy&#7871;t áp t&#432; th&#7871;). Thu&#7889;c ch&#7865;n
beta có th&#7875; &#7843;nh h&#432;&#7903;ng t&#7899;i tác d&#7909;ng ho&#7863;c
n&#7891;ng &#273;&#7897; c&#7911;a ethanol, disopyramid, thu&#7889;c giãn
c&#417; không kh&#7917; c&#7921;c và theophylin, tuy nhiên tác d&#7909;ng khó
tiên &#273;oán &#273;&#432;&#7907;c.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897;
&#7893;n &#273;&#7883;nh và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Viên nén
nadolol &#273;&#432;&#7907;c b&#7843;o qu&#7843;n trong l&#7885; kín, tránh ánh
sáng, &#7903; nhi&#7879;t &#273;&#7897; không quá 25<sup>o</sup>C.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Quá
li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<h2 align=left style='text-align:left;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;font-weight:normal'>Tri&#7879;u ch&#7913;ng
quá li&#7873;u g&#7891;m r&#7889;i lo&#7841;n v&#7873; tim, &#273;&#7897;c h&#7841;i
cho h&#7879; th&#7847;n kinh trung &#432;&#417;ng (TKT&#431;), co th&#7855;t ph&#7871;
qu&#7843;n, h&#7841; &#273;&#432;&#7901;ng máu và t&#259;ng kali huy&#7871;t.
Tri&#7879;u ch&#7913;ng tim th&#432;&#7901;ng g&#7863;p nh&#7845;t g&#7891;m gi&#7843;m
huy&#7871;t áp và ch&#7853;m nh&#7883;p tim; bl&#7889;c nh&#297; - th&#7845;t,
r&#7889;i lo&#7841;n d&#7851;n truy&#7873;n trong tâm th&#7845;t, s&#7889;c do
tim, và có th&#7875; x&#7843;y ra suy tim khi dùng quá li&#7873;u nghiêm tr&#7885;ng.
Tác d&#7909;ng trên h&#7879; TKT&#431; g&#7891;m co gi&#7853;t, hôn mê và ng&#7915;ng
hô h&#7845;p.<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Vi&#7879;c
&#273;i&#7873;u tr&#7883; g&#7891;m &#273;i&#7873;u tr&#7883; tri&#7879;u ch&#7913;ng
c&#417;n &#273;&#7897;ng kinh, các ch&#7913;ng gi&#7843;m huy&#7871;t áp,
t&#259;ng kali huy&#7871;t và gi&#7843;m &#273;&#432;&#7901;ng máu. Nh&#7883;p
tim ch&#7853;m và gi&#7843;m huy&#7871;t áp khi kháng l&#7841;i atropin,
isoproterenol ho&#7863;c máy t&#7841;o nh&#7883;p, có th&#7875; &#273;áp &#7913;ng
v&#7899;i glucagon.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dùng nhi&#7873;u
li&#7873;u than ho&#7841;t, truy&#7873;n máu, ho&#7863;c th&#7849;m tách máu ch&#7881;
có th&#7875; giúp lo&#7841;i tr&#7915; các thu&#7889;c ch&#7865;n beta có th&#7875;
tích phân b&#7889; nh&#7887;, n&#7917;a &#273;&#7901;i dài nh&#432; nadolol.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thông
tin qui ch&#7871;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
&#273;&#7897;c b&#7843;ng B.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thành ph&#7849;m
gi&#7843;m &#273;&#7897;c: Thu&#7889;c viên có hàm l&#432;&#7907;ng t&#7889;i
&#273;a là 80 mg.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Nadolol.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:06 GMT -->
</html>
